Palmer R A, Tran D, Hepburn N C, Ashton R E
Department of Dermatology, Royal Hospital Haslar, Gosport, UK, County Hospital, Lincoln, UK.
Clin Exp Dermatol. 2001 Jan;26(1):16-20. doi: 10.1046/j.1365-2230.2001.00751.x.
We report 20 patients who contracted cutaneous leishmaniasis in Central and South America, 18 of them in Belize. The diagnosis was confirmed by the polymerase chain reaction (PCR) in 79% of those tested; the corresponding figure for histology was 62%, touch smear 46%, and culture 11%. Results of PCR can be falsely positive, so treatment should not be based on PCR alone. Of the 20 cases 18 were healed 6 weeks after intravenous sodium stibogluconate 20 mg/kg per day for 20 days. We present a management protocol.
我们报告了20例在中美洲和南美洲感染皮肤利什曼病的患者,其中18例在伯利兹。79%的受测患者通过聚合酶链反应(PCR)确诊;组织学确诊率为62%,触片检查为46%,培养为11%。PCR结果可能出现假阳性,因此不应仅基于PCR进行治疗。20例患者中有18例在每天静脉注射20mg/kg葡萄糖酸锑钠,持续20天后,6周内痊愈。我们提出了一个管理方案。